Cor Vasa 2007, 49(11):426-430 | DOI: 10.33678/cor.2007.145

Inflammatory cardiomyopathy secondary to borrelia infection, without a systemic serologic response

Petr Kuchynka1, Tomáš Paleček1, Stanislav Šimek1, Dagmar Hulínská2, Sudheera Magage1, Gabriela Dostálová1, Štěpán Havránek1, Aleš Linhart1
1 II. interní klinika kardiologie a angiologie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy
2 Národní referenční laboratoř pro Lymeskou borreliózu, Státní zdravotní ústav, Praha, Česká republika

Lyme carditis is the term used for cardiac involvement caused by infection by the spirochete Borrelia burgdorferi. The disease manifestations include mostly arrhythmias, with pericarditis or myocardial dysfunction being less common. The authors describe a case of Lyme cardiomyopathy with severe left ventricular systolic dysfunction. The final diagnosis was based solely on endomyocardial biopsy as the serological examination did not reveal any presence of specific antibodies against Borrelia. Subsequent antibiotic therapy with cephalosporins led to complete normalization of left ventricular systolic function. This case underlines the significance of performing endomyocardial biopsy in patients with suspected inflammatory cardiomyopathy.

Keywords: Lyme disease; Inflammatory cardiomyopathy; Endomyocardial biopsy

Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuchynka P, Paleček T, Šimek S, Hulínská D, Magage S, Dostálová G, et al.. Inflammatory cardiomyopathy secondary to borrelia infection, without a systemic serologic response. Cor Vasa. 2007;49(11):426-430. doi: 10.33678/cor.2007.145.
Download citation

References

  1. Bartůněk P, Mrázek V, Goričan K, et al. Postižení srdce v průběhu Lymeské borreliózy. Čas Lék čes 2005;144: 30-6.
  2. Lobovská A. Lymská borrelióza. V: Lobovská A. Infekční nemoci. Praha: Karolinum, 2002:130-2.
  3. Bartůněk P. Lymeská karditida. V: Aschermann M, et al. Eds. Kardiologie. Praha: Galén, 2004:847-51.
  4. Klein J, Stanek G, Bittner R. Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J 1991;12:73-5. Go to original source... Go to PubMed...
  5. Van der Linde MR. Lyme carditis in Europe: clinical features in 66 documented cases. In: Abstracts from IV International Conference on Lyme borreliosis. Book B. Stockholm, 1990:111.
  6. Seinost G, Gasser R, Reisinger E. Cardiac manifestations of Lyme Borreliosis with special reference to contractile dysfunction. Acta Med Austriaca 1998;25:44-50. Go to PubMed...
  7. Gasser R, Reisenger E, Eber B. Cases of Lyme borreliosis resistent to conventional treatment: improved symptoms with cephalosporin plus specific betalactamase inhibition. Mikrob Drug Resist 1995;1:341-4. Go to original source... Go to PubMed...
  8. Wormser GP, Nadelman RB, Datwyller J. Practice guidelines for the treatement of Lyme disease. Clin Infect Dis 2000;31:1-14. Go to original source...
  9. Noutsias M, Pauschinger M, Schultheiss HP, Kühl U. Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J 2002;4 (Suppl I):154-62. Go to original source...
  10. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of imunosuppressive therapy for myocarditis. New Engl J Med 1995;333:269-75. Go to original source... Go to PubMed...
  11. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593-5. Go to original source... Go to PubMed...
  12. Staudt A, Schaper F, Stangl V, et al. Imunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substition. Circulation 2001;103:2681-6. Go to original source... Go to PubMed...
  13. Bowles NE, Kearney DL, Pauschinger M. Detection of viruses in myocardial tissues by polymerase chain reaction. J Am Coll Cardiol 2003;42:473-6. Go to original source... Go to PubMed...
  14. Hulínská D, Dřevová H, Votýpka J, Langrová K, Kurzová Z. Prevalence of Borrelia burgdorferi sensu lato species among patients in Czech republic: direct sequencing analysis and real-time polymerase chain reaction. Epidemiol Microbiol Imunol 2004;53:183-91.
  15. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosupresive treatment of inflammatory dilated cardiomyopathy. Two year follow-up results. Circulation 2001;104:39-45. Go to original source... Go to PubMed...
  16. Frustraci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosupresive therapy for aktive lymphocytic myocarditis. Virological and immunological profile of responders versus nonresponders. Circulation 2003;107:857-63. Go to original source... Go to PubMed...
  17. Felix SB, Staudt A, Baumann G. Immunoadsorption as a new therapeutic principle for treatment of dilated cardiomyopathy. Eur Heart J 2002;4 (Suppl I):163-8. Go to original source...
  18. Kühl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patiens with myocardial persistence of viral genom and left ventricular dysfunction. Circulation 2003;107:2973-98. Go to original source... Go to PubMed...
  19. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23. Go to original source... Go to PubMed...
  20. Klein J, Stanek G, Bittner R, Horvat R, Holzinger C, Glogar D. Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J 1991;12:73-5. Go to original source... Go to PubMed...
  21. Bartůněk P, Mrázek V, Goričan K, Bína R, Listvanová S, Zapletalová J. Borrelia infection as a cause of carditis (a long-term study). Wien Klin Wochenschr 2001;113: 38-44.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.